ANG Lifesciences India Ltd (540694) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540694 | NSE: | Pharmaceuticals & Drugs | Small Cap

ANG Lifesciences Share Price

28.99 0.18 0.62%
as on 05-Dec'25 12:15

ANG Lifesciences India Ltd (540694) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540694 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on ANG Lifesciences

Based on:

M-Cap below 100cr DeciZen not available

ANG Lifesciences India stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
37.6 Cr.
52-wk low:
21
52-wk high:
49.7

Is ANG Lifesciences India Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of ANG Lifesciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
ANG Lifesciences India Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 23.4%29.7%22.2%23.7%22.4%19.9%53.8%9.2%0.7%-4%-
Value Creation
Index
0.71.10.60.70.60.42.8-0.3-1.0-1.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 54.967.77612212715434920713189.992
Sales YoY Gr.-23.2%12.4%60.1%4.2%21.6%126%-40.6%-36.5%-31.6%-
Adj EPS 1.83.12.94.54.95.630.7-0.3-5.7-7.7-6.2
YoY Gr.-70.6%-6.5%57.1%9.5%13.2%449.9%-100.9%NANA-
BVPS (₹) 5.28.117.922.226.731.964.465.55951.250
Adj Net
Profit
1.72.83.75.86.47.339.8-0.4-7.5-10-8
Cash Flow from Ops. 1.94.50.97.54.8-11.227.426-13.1-2.3-
Debt/CF from Ops. 7.3321.22.94.3-3.82.22-4.3-29.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.6%-6.7%-36.4%-31.6%
Adj EPS -217.5%-209.2%-163%NA
BVPS29%13.9%-7.4%-13.3%
Share Price - -1.7% -40.6% -38%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
4246.124.322.520.219.163.8-0.4-9.2-13.9-12.3
Op. Profit
Mgn %
8.6109.91010.49.918.95.97.4-1.11.9
Net Profit
Mgn %
34.24.94.85.14.711.4-0.2-5.7-11.2-8.8
Debt to
Equity
2.81.80.80.80.610.70.60.710.1
Working Cap
Days
139168198152180223155299439603329
Cash Conv.
Cycle
142851567265369813320037

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - ANG Lifesciences India Ltd.

Standalone Consolidated
TTM EPS (₹) -6.2 -9.4
TTM Sales (₹ Cr.) 92.1 92.2
BVPS (₹.) 50 45.2
Reserves (₹ Cr.) 52 46
P/BV 0.58 0.64
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 21.03 / 49.73
All Time Low / High (₹) 10.62 / 640.36
Market Cap (₹ Cr.) 37.6
Equity (₹ Cr.) 13.1
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of ANG Lifesciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *44.8844.8844.8844.8844.8844.8844.8844.8844.8844.88
* Pledged shares as % of Promoter's holding (%)

Valuation of ANG Lifesciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of ANG Lifesciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales54.9267.6776.04121.70126.83154.28348.67207.01131.3789.91
Operating Expenses 50.1960.9068.54109.87114.15138.94283.12195.35121.8191.38
Manufacturing Costs04.245.207.558.9510.4714.7612.126.406.19
Material Costs40.8647.7752.8987.8488.97103.96230.01146.9087.2060.59
Employee Cost 3.474.125.646.397.2414.3518.3220.2715.9014.45
Other Costs 5.874.774.818.098.9910.1620.0316.0512.3110.15
Operating Profit 4.736.777.5011.8312.6815.3365.5411.669.55-1.47
Operating Profit Margin (%) 8.6%10.0%9.9%9.7%10.0%9.9%18.8%5.6%7.3%-1.6%
Other Income 0.210.250.690.230.420.750.959.840.842.44
Interest 1.662.042.042.833.463.988.3110.929.777.64
Depreciation 1.061.171.191.121.232.245.128.527.756.27
Exceptional Items 00000000-1.740
Profit Before Tax 2.223.814.958.118.419.8653.062.07-8.87-12.94
Tax 0.570.991.232.462.312.6113.352.73-0.22-2.59
Profit After Tax 1.652.823.725.656.107.2539.71-0.66-8.65-10.34
PAT Margin (%) 3.0%4.2%4.9%4.6%4.8%4.7%11.4%-0.3%-6.6%-11.5%
Adjusted EPS (₹)1.83.12.94.44.75.630.7-0.5-6.6-7.9
Dividend Payout Ratio (%)0%0%0%0%0%0%3%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 4.777.4923.1728.7734.5641.3683.4885.5477.0766.81
Share Capital 3.683.685.185.185.185.1810.3713.0613.0613.06
Reserves 1.093.8117.9923.5829.3736.1773.1172.4864.0253.75
Minority Interest0000000000
Debt11.7711.5814.0818.6918.1739.2153.5949.9252.2564.11
Long Term Debt6.814.967.686.285.255.9312.0110.066.9713.34
Short Term Debt4.966.616.4012.4112.9233.2841.5939.8545.2850.77
Trade Payables15.0821.3922.3221.8125.7945.2466.2761.9558.1855.42
Others Liabilities 3.876.388.6011.6215.5616.0365.3455.1129.9321.10
Total Liabilities 35.4946.8468.1780.9094.08141.83268.68252.51217.43207.44

Fixed Assets

Gross Block17.1818.3031.5632.4133.9637.54103.07107.9485.3990.95
Accumulated Depreciation8.169.3310.5211.6512.7915.6520.7529.2632.0538.32
Net Fixed Assets 9.028.9721.0420.7621.1721.8982.3278.6853.3552.63
CWIP 000000.400000
Investments 0.020.020.020.020.020.023.523.523.523.52
Inventories5.245.847.746.541019.2629.1737.3934.2437.84
Trade Receivables16.3825.5632.1541.7546.0658.7898.9978.1169.2764.96
Cash Equivalents 1.030.911.484.373.600.116.596.055.503.55
Others Assets 3.805.545.737.4613.2241.3648.1048.7551.5544.94
Total Assets 35.4946.8468.1780.9094.08141.83268.68252.51217.43207.44

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 1.864.510.887.464.83-11.1827.3926.01-13.13-2.29
PBT 2.222.823.728.118.419.8653.062.07-8.87-12.94
Adjustment 2.673.6943.404.105.8714.8318.3417.4611.74
Changes in Working Capital -2.61-1.13-5.81-1.68-5.02-26.29-39.928.96-8.323.09
Tax Paid -0.42-0.87-1.03-2.37-2.65-0.63-0.58-3.36-13.40-4.19
Cash Flow From Investing Activity -2.92-1.15-13.40-0.77-1.66-7.79-42.50-9.3520.02-1.63
Capex -1.31-1.12-13.26-0.84-1.64-4.07-39.35-10.4319.06-4.12
Net Investments 00000-3.92-3.430.450.441.94
Others -1.61-0.03-0.140.07-0.010.200.280.630.520.55
Cash Flow From Financing Activity 1.63-3.4813.10-3.80-3.9518.8115.29-16.75-73.92
Net Proceeds from Shares 0012.010000200
Net Proceeds from Borrowing -1.30-1.852.72-1.41-1.032.3410.40-6.51-3.096.54
Interest Paid 0-1.53-1.58-2.34-2.87-3.58-6.60-10.19-8.95-6.99
Dividend Paid 000000-1.04000
Others 2.93-0.10-0.05-0.05-0.0520.0512.52-2.045.044.36
Net Cash Flow 0.56-0.120.572.89-0.77-0.160.17-0.08-0.12-0.01

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)41.9746.0624.2921.7519.2519.163.62-0.78-10.64-14.38
ROCE (%)23.3629.6622.2323.6622.3919.953.789.180.66-3.96
Asset Turnover Ratio1.791.641.321.631.451.311.70.790.560.42
PAT to CFO Conversion(x)1.131.60.241.320.79-1.540.69N/AN/AN/A
Working Capital Days
Receivable Days7511313811112612483156205272
Inventory Days3830332124352559100146
Payable Days111139151929812588159251342

ANG Lifesciences India Ltd Stock News

ANG Lifesciences India Ltd FAQs

The current trading price of ANG Lifesciences on 05-Dec-2025 12:15 is ₹28.99.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of ANG Lifesciences stood at ₹37.62.
The latest P/E ratio of ANG Lifesciences as of 04-Dec-2025 is 0.00.
The latest P/B ratio of ANG Lifesciences as of 04-Dec-2025 is 0.58.
The 52-week high of ANG Lifesciences is ₹49.73 and the 52-week low is ₹21.03.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of ANG Lifesciences is ₹92.08 ( Cr.) .

About ANG Lifesciences India Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×